Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Lloyd-Smith Malcolm
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
Avg. Two Year Performance
No purchase track record
(16%)
Avg. Sale Return
(8%)
Compound
1 Mo
3 Mo
6 Mo
1 Yr
2 Yr
Average Purchase Return
--
--
--
--
--
Purchase Success Rate
--
--
--
--
--
Average Sale Return
4%
(< 1%)
(6%)
(5%)
(16%)
Sale Success Rate
11 of 21
12 of 21
4 of 21
3 of 21
1 of 21
Neurocrine Biosciences Inc.
Drugs
» Biotechnology
Chief Integration Officer:
Holdings:
42.34K
shares
Sentiment
Avg. Two Year Performance
No purchase track record
No sale track record
Last Three Months:
0
Net Amount
Buy:
0
--
Sell:
0
--
Cadence Pharmaceuticals Inc.
Drugs
» Biotechnology
SVP, Reg Affairs, Qual & Clin:
Holdings: 0 shares
Sentiment
Avg. Two Year Performance
No purchase track record
No sale track record
Last Three Months:
0
Net Amount
Buy:
0
--
Sell:
0
--